Spyre Therapeutics
SYRE
#4929
Rank
C$2.01 B
Marketcap
$34.28
Share price
3.16%
Change (1 day)
42.32%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -C$0.27 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.19 Billion a decrease over its 2022 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.27 Billion42.55%
2023 -C$0.19 Billion51.64%
2022 -C$0.13 Billion29.14%
2021 -C$94.33 Million-19.43%
2020 -C$0.12 Billion1.43%
2019 -C$0.12 Billion76.7%
2018 -C$65.33 Million64.27%
2017 -C$39.77 Million26.34%
2016 -C$31.48 Million93.6%
2015 -C$16.26 Million27.08%
2014 -C$12.8 Million